The Global Genome Editing Market size is estimated to reach USD 11.59 billion by 2027, from USD 4.36 billion in 2019, delivering a CAGR of 14.8% through the forecast period, according to a new report by Reports and Data. Genome editing refers to a  genetic engineering method used for insertion, deletion, or modification in the genome of any organism. Genome editing has come up as promising tool with wide scale application of established genetic engineering technologies such as TALEN and introduction of new methods such as CRISPR technology.

The market is driven by the increasing incidence of genetic diseases, favorable funding scenario for research & development in the field of genetic engineering, technological advancements in genetic engineering such as developments in CRISPR technology, increasing focus of food industry on genetically modified organisms, and rising awareness about efficacy as well applications of genetic engineering methods. For instance, globally over 175 million hectares of land is used for GM crops production. However, stringent regulatory scenario and ethical concerns for gene editing research and applications and concerns among end users regarding use of gene alteration therapies are likely to hinder the market growth during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1052  

Key companies operating in the global market and profiled in the report include:

Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs and Sangamo Therapeutics, Inc.

Further key findings from the report suggest

• CRISPR market is rising at a high growth rate of 30.9 percent in Asia Pacific followed by North America and Europe. Rising application of genetic engineering for therapeutics will drive the demand for the market during forecast period across all regions.
• Asia Pacific is expected to witness a CAGR of 15.8 percent in the forecast period. Emerging markets such China and Japan are likely to witness high growth
• Regional regulatory approval is another key regulatory factor for adoption and growth of genetic editing in the region.

For the purpose of this report, Reports and Data has segmented the Genetic Editing market on the basis of type, application, end user and region:

Type Outlook (Revenue, USD Million, 2016 - 2026)

• • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Transcription Activator-Like Effector Nucleases (TALEN)
  • Zinc Finger Nucleases (ZFN)
  • Others

Application Outlook (Revenue, USD Million, 2016 - 2026)

• • Animal Genetic Engineering
    • Therapeutic Application
    • Genetically Modified Organisms
  • Plant Genetic Engineering
  • Cell Line Engineering

End User Outlook (Revenue, USD Million, 2016 - 2026)

• • Pharma-Biotech Companies
  • Academic Institutes & Research Center
  • Agrigenomic Companies
  • Contract Research Organizations

Regional Outlook (Revenue, USD Million, 2016 - 2026)

• • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • Middle East & Africa

To know more about the report @ https://www.reportsanddata.com/report-detail/genome-editing-market

The report utilizes advanced analytical tools to research, gather, and analyze data. The in-depth research report has been formulated through extensive primary and secondary research and the data has been further validated and verified from industry experts, professionals, and research analysts. The report also offers strategic recommendations to key market players and novice players to overcome barriers and limitations and gain a robust footing in the market.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1052

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.

Read More Reports:-

Hemostasis Analyzers Market Analysis, By Product (Laboratory analyzer, POC testing,) By Test Type (Prothrombin Time, Fibrinogen, Activated Partial and others) By Technology Type (Mechanical and others) By End-Use (Diagnostic Centers, Hospitals, and others), Forecasts to 2026 Product (Revenue, USD Million; 2016-2026)

Non-Invasive Brain Trauma Monitoring Devices Market Size, Share and Analysis By Type (Monitoring Devices, Accessories) By Application (Traumatic Brain Injuries, Parkinson, Headache disorders, Epilepsy, Other Applications) By End-User, Forecast to 2027

Healthcare Mobility Solutions Market Analysis, By Products and Services (Mobile Devices, Mobile Applications, Mobile Enterprise Solutions), Application (Enterprise Solutions, mHealth Applications), End-Use (Payers, Providers, and Patients), Forecasts to 2026